These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25497458)

  • 1. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.
    Lesho EP; Clifford RJ; Chukwuma U; Kwak YI; Maneval M; Neumann C; Xie S; Nielsen LE; Julius MD; McGann P; Waterman PE
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):119-25. PubMed ID: 25497458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
    Muller A; Bertrand X; Rogues AM; Péfau M; Alfandari S; Gauzit R; Dumartin C; Gbaguidi-Haore H;
    Antimicrob Resist Infect Control; 2018; 7():11. PubMed ID: 29387345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
    Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in Northern Taiwan.
    Hsieh WS; Wang NY; Feng JA; Weng LC; Wu HH
    J Antimicrob Chemother; 2014 Oct; 69(10):2871-3. PubMed ID: 25140578
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of Defense.
    Lesho E; Chukwuma U; Sparks M; Neumann C; Richesson D; Clifford R; Gierhart S; Waterman P; Hinkle M
    J Clin Microbiol; 2016 Jun; 54(6):1546-1551. PubMed ID: 27030488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
    Bitterman R; Geffen Y; Rabino G; Eluk O; Warman S; Greenblatt AS; Neuberger A; Reisner SA; Hussein K; Paul M
    Am J Infect Control; 2016 Sep; 44(9):1053-4. PubMed ID: 27125914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
    Ho CM; Ho MW; Liu YC; Toh HS; Lee YL; Liu YM; Huang CC; Lu PL; Liu CE; Chen YH; Ko WC; Tang HJ; Yu KW; Chen YS; Chuang YC; Wang JH; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S24-8. PubMed ID: 22749055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India.
    Datta P; Gupta V; Singla N; Chander J
    Indian J Med Microbiol; 2015; 33(4):612-3. PubMed ID: 26470985
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.
    Moran Gilad J; Carmeli Y; Schwartz D; Navon-Venezia S
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):565-7. PubMed ID: 21767716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The genotype and epidemiological feature of the Enterobacteriaceae carrying carbapenemase in China].
    Zhang J; Liu Y; Chen H; Cao B; Gao H; Li H; Wang H
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):116-20. PubMed ID: 24767163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015.
    Wilson BM; El Chakhtoura NG; Patel S; Saade E; Donskey CJ; Bonomo RA; Perez F
    Emerg Infect Dis; 2017 May; 23(5):878-880. PubMed ID: 28418318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital signs: carbapenem-resistant Enterobacteriaceae.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Abboud CS; Monteiro J; Stryjewski ME; Zandonadi EC; Barbosa V; Dantas D; Sousa EE; Fonseca MJ; Jacobs DM; Pignatari AC; Kiffer C; Rao GG
    Int J Antimicrob Agents; 2016 May; 47(5):386-90. PubMed ID: 27155944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.